
Financial Data and Key Metrics Changes - In Q4 2023, net sales totaled $36.1 million, a 1.2% increase from $35.6 million in Q4 2022 and up approximately 8% sequentially [9] - For the full year 2023, net sales reached $139.3 million, up nearly 4% from the prior year, driven by growth in medical, aerospace and defense, and industrial sectors [10] - Gross profit for 2023 was $23.1 million or 16.6%, compared to $20.5 million or 15.3% in 2022, indicating gross margin expansion [11] - Operating expenses totaled $17.2 million, a 3.4% increase from $16.6 million in 2022, primarily due to increased general and administrative expenses [12] - Fourth quarter 2023 GAAP net income was $6.9 million or $2.38 per diluted share, compared to $2 million or $0.70 per diluted share in 2022 [15] - EBITDA for 2023 increased 38.2% to $8 million, compared to $5.8 million in 2022, largely due to increased sales [17] Business Line Data and Key Metrics Changes - Medical market sales increased by $2.8 million or 3.7% in 2023, primarily from medical component products [10] - Aerospace and defense category net sales totaled $20.5 million, a 5.1% increase from the prior year [11] - Industrial category net sales were $40.1 million, up $3.6 million from the prior year [11] Market Data and Key Metrics Changes - The company noted a normalization in supply chain and customer ordering practices, which had previously influenced backlog levels [34] - The trend of near-shoring is gaining attention, with Mexico surpassing China in U.S. imports for the first time in 20 years [35] Company Strategy and Development Direction - The company emphasizes an employee-first mindset in its strategic planning, recognizing employees as valuable assets [31] - Nortech's three-tiered global manufacturing strategy in the U.S., Mexico, and China allows flexibility in production based on customer needs [36] - The company is focused on strengthening its balance sheet and delivering sustained EBITDA growth [47] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to manage challenges and continue growth, citing strong employee dedication and strategic planning [74] - The company anticipates continued sales momentum in 2024, supported by stabilization in supply chain and customer orders [71] Other Important Information - The company replaced its asset-backed line of credit with a cash flow-backed $15 million senior secured revolving line of credit, expiring in February 2027 [21][22] - Cash and cash equivalents as of December 31, 2023, totaled $1.7 million, reflecting fluctuations due to timing of cash receipts and expenditures [46] Q&A Session Summary Question: Comment on Nortech's accomplishments in the last five years and future direction - Management highlighted significant changes in the business, emphasizing employee dedication and a focus on strategic planning for continued growth [73] Question: What drove the improvement in gross margins? - The improvement was attributed to increased revenue covering fixed costs and effective cost management, alongside operational excellence [59][62] Question: Is the sales improvement sustainable? - Management expressed confidence in the ability to manage the business effectively and expand margins, indicating a positive outlook for future sales [78] Question: Insights on backlog normalization and sales improvement - Management noted that while backlog normalization was expected, the company has proven its ability to execute better than competitors and anticipates closing more business [79]